3 Things Amgen Inc.'s Management Just Said That You'll Want to Know

3 Things Amgen Inc.'s Management Just Said That You'll Want to Know

It's been a great 2017 for Amgen (NASDAQ: AMGN) shareholders so far. Amgen stock is up close to 30%. The company announced several positive developments from its pipeline. Still, though, some questions remain about what's next for the big biotech.

Amgen CEO Robert Bradway and CFO David Meline sat down on Tuesday at the Morgan Stanley healthcare conference to answer some of those questions. Here are three things the Amgen executives said that investors will want to know. 

Image source: Getty Images.

Continue reading

Source: Fool.com